Lil­ly part­ners with Unit­ed­Health to con­duct 're­al-world' study for its Covid-19 an­ti­body bam­lanivimab

As Eli Lil­ly con­tin­ues to build out da­ta for their FDA-au­tho­rized Covid-19 treat­ment bam­lanivimab, they’ve been seek­ing new part­ners to con­duct more tri­als. And the …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.